8 employees
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
2015
$3M
from 2 investors over 2 rounds
Hemispherian AS raised $3M on November 24, 2022
Investors: Meneldor and Kistefos AS